3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
2
Genitourinary
1
Conditions
Metastatic Castration Resistant Prostate Cancer
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Adenocarcinoma
1
Interventions
pembrolizumab
6
Radiosurgery
5
Docetaxel
5
enzalutamide
4
darolutamide
3
Radiotherapy
3
Everolimus
3
Androgen Antagonists
3
relugolix
2
luprolide acetate gel depot
2
Surveys and Questionnaires
2
Standard of Care
2
Radiotherapy, Image-Guided
2
Radiofrequency Ablation
2
Panobinostat
2
Leuprolide
2
Abiraterone Acetate
2
trastuzumab deruxtecan
1
talazoparib
1
spartalizumab
1
siremadlin
1
sipuleucel-T
1
sargramostim
1
resiquimod
1
polysaccharide-K
1
poly ICLC
1
palbociclib
1
olaparib
1
liposomal doxorubicin
1
ixabepilone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
apatinib
×
Genitourinary
×
Clear all
NCT03407976
2020-07-15
APPEASE
University of Utah
Phase 1
Terminated
5 enrolled